Magnetic Resonance Imaging (or MRI) plays an important role in detecting, diagnosing, and monitoring different diseases in the body. We often use contrast-enhanced MRI, which enhances and improves the quality of the MRI images. This type of MRI involves an injection of a chemical substance often called gadolinium-based contrast agent.
In this study we aim to develop novel imaging methods for cancer diagnostics and treatment monitoring. When developing a new method, we need healthy volunteers to help define the limits of "normal." Healthy volunteers are given the same procedure that the patient group receives. Investigators learn about the disease process by comparing the healthy volunteers’ images to the cancer patients’ images.
We hope that the new MRI methods can improve imaging of cancer and increase our understanding of cancer biology. In the future, this could lead to better clinical decisions and improved patients’ quality of life.
